EMEA accepts regadenoson MAA

EMEA accepted for review an MAA from Gilead Sciences Inc. (NASDAQ:GILD) for regadenoson for use as a pharmacologic stress agent in myocardial perfusion imaging. Gilead gained the A2A adenosine recepto...